treatment news

US FDA approves nivolumab immunotherapy for liver cancer

The US Food and Drug Administration last week granted accelerated approval for nivolumab (Opdivo), an immunotherapy drug that restores T-cell anti-tumour activity, for people with hepatocellular carcinoma. Nivolumab, an antibody that blocks the PD-1 receptor, was...

read more

HIV diagnoses on the rise among over-50s in Europe

Just over one in six people diagnosed with HIV in Europe between 2004 and 2015 was over 50 years of age, and new diagnoses in older people increased in 16 European countries across the same period, a study published today in The Lancet HIV shows. The study found that...

read more

Marathon training is safe for people with HIV

Marathon run training is safe for people with HIV, investigators from Germany report in BMC Infectious Diseases. Training also had a number of beneficial effects, including a significant increase in CD4 cell count and improvements in cholesterol and blood pressure,...

read more